Latest Strategy Changes News

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Avira Resources has significantly expanded its Tangadee Project in Western Australia and is preparing to drill three high-potential EM targets, while advancing its capital raising efforts to fund exploration.

BOA Resources is progressing its 2025 drilling plans across key lithium and nickel tenements in Western Australia, while managing delays in heritage surveys and optimizing its tenement portfolio to focus on high-potential assets.

BOA Resources Ltd reported a steady cash position of AUD 1.067 million at the end of Q1 2025, underpinning an estimated four quarters of operational funding. The quarterly cash flow report highlights disciplined spending amid ongoing exploration activities.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

Holista Colltech has closed its ASIC penalty chapter with a $900K final payment, raised $1.53 million through convertible notes, and reported a 10.9% year-on-year sales increase driven by its Dietary Supplements division.

Electro Optic Systems (EOS) reported a robust quarter ending March 2025, highlighted by significant new defence contracts and a strong cash position following the divestment of its EM Solutions subsidiary.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

Identitii Limited advances its BNDRY platform with new agreements targeting hospitality and payments sectors, appoints Tim Phillipps as Executive Chair, and reports stable cash flow amid ongoing patent litigation.

Radiopharm Theranostics has bolstered its cash position with an $8 million placement from Lantheus Holdings, now its largest shareholder. New clinical data highlight promising advances in brain metastases detection and HER2-targeted radiopharmaceutical therapies.